FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer Read more
Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients Read more
Bavarian Nordic receives FDA Orphan Drug Designation for BN-Brachyury for the treatment of Chordoma Read more
Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer Read more
AbbVie Submits BLA to FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more